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Abstract
Many colour tests require a visual acuity of at least 0.1, making them unsuitable for low vision patients. To assess colour vision
in patients with sub-normal acuity, we re-designed a previously described test so that its spatial details would be coarse enough
to be resolvable by subjects with severe visual impairment. The test measures chromatic discrimination along 20 axes evenly
spaced in CIE 1976 L*u*6* colour space. We detail the results for this test in a group of patients with dominant optic atrophy.
Despite the lack of evidence for genetic heterogeneity in dominant optic atrophy, we observed phenotypic variation both between
and within families. © 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Many colour vision tests require a minimum visual
acuity of around 0.1 (6:60) [1], although some tests,
such as the enlarged D-15, and the computer controlled
test described by Arden et al. [2] can be used with the
visually impaired. Although this dependence on visual
acuity is not a drawback in assessing congenital colour
deficiencies, it is a limitation when assessing those
patients with colour deficiency secondary to ocular or
systemic pathology, because in many cases a colour
defect will only develop once visual acuity falls below
0.6 (6:10) [3].
Dominant optic atrophy (DOA) is a hereditary optic
atrophy characterised by moderate to severe visual
impairment with an insidious onset, a centro-caecal
scotoma and dyschromatopsia. The disease follows
Mendelian rules for autosomal dominant traits, display-
ing a high penetrance (0.98), but variable expressivity
[4,5]. The onset of the disease is early in life, perhaps
even within the first year, although some patients re-
main undiagnosed until late childhood:adolescence. Vi-
sual acuity ranges from being as good as 1 (6:6) to as
poor as 0.05 (6:120) or less. The primary ophthalmo-
scopically visible abnormality is pallor of the optic
nerve head, which may be confined to the temporal side
of the nerve head. The condition has been linked to
chromosome 3q28-qter in French [6], Cuban [7], Dan-
ish [8], American [9] and English [10,11] pedigrees,
making it increasingly unlikely that a second locus for
the condition will be found. The pathogenesis of the
condition is as yet unknown, but histopathological
studies do suggest that there is a loss of ganglion cells,
particularly of those cells constituting the papillomacu-
lar bundle [12,13]. These findings are consistent with
the electrophysiological picture: patients with DOA
show pattern ERG deficits suggestive of ganglion cell
pathology [14–16].
It is quite commonly stated in ophthalmologic texts
that DOA invariably causes a tritan colour vision defi-
ciency [17,18]. The seminal monograph by Kjer [4]
reported that the colour defect is predominantly tritan.
His findings were confirmed by Eliott et al., Hansen,
Kline and Glaser, and Ohba et al. [19–22]. Krill et al.
[23] reported that DOA was capable of mimicking
congenital tritanopia, although the magnitude and spe-
cificity of the of colour defect could vary dramatically
within families. Some families may display predomi-
nantly red-green deficiencies [24–27]. Roggeveen et al.
1985 [1] proposed that such phenotypic variations
reflect genetic heterogeneity.* Corresponding author. Fax: 44 1223 333564.
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Table 1
Results for normal subjects
Ellipse (A, B) u SubjectSubject AgeAge Ellipse (A, B) u
R (4.7, 9) 55.5 MRSAP 5736 R (6.2, 8.7) 132.3
L (4.3, 8.5) 48.9 L (7.2, 8.8) 42.4
R (4.1, 7.5) 47.0 MPRO’K 5828 R (5.0, 7.4) 69.8
L (4.7, 9.1) 51.4 L (4.7, 9.1) 86.3
R (4.7, 9) 53.5 TSJS 3228 R (4.7, 10.6) 54.0
L (6.3, 11) 54.9 L (5.5, 11.6) 53.5
R (5.2, 11.1) 73.2 MSCA 4035 R (6.1, 14.4) 73.2
L (5.8, 8.9) 54.4 L (7.3, 11.3) 36.5
R (6.7, 9.3) 73.0 LPPD 4234 R (8.0, 10.3) 73.2
L (6.5, 9.9) 79.2 L (8.2, 17.6) 70.29
R (4.9, 8.3) 77.0 SFCG 3458 R (4.5, 11.1) 74.3
L (4.4, 7) 79.5 L (5.3, 8.6) 61.4
TPS R (6.4, 10.5) 89.746 AS 44 R (4.9, 10.6) 52.4
L (7.8, 9.0) 177.8 L (5.7, 8) 80.5
R (4.9, 9.3) 86.3 SRLW 2936 R (4.5, 7.5) 72.8
L (5.4, 7.8) 74.2 L (4.3, 7.6) 64.9
R (5.9, 9.6) 99.0TW 61
L (5.3, 7.3) 51.4
The columns headed ‘ellipse’ give, for right and left eyes, the lengths of the minor and major axes (A, B) and angle of the major axis (u) of the
ellipse fitted to the chromatic thresholds. Units are 1000 times their value in the CIE 1976 u % 6 % diagram.
In order to assess colour vision in DOA, we aimed to
design a colour test that requires only a minimum level
of acuity. In addition the test should be capable of
assessing patients with normal acuity, so that colour
vision could be assessed in patient groups with a wide
array of visual acuities. The same features would also
mean that changes in colour vision could be monitored
over time in conditions where there is a gradual loss in
visual acuity. We have used this test to examine resid-
ual colour vision in a group of DOA patients, and to




A group of 17 subjects from nine families was assem-
bled from a molecular genetic study of DOA being
conducted at the Institute of Ophthalmology, London.
The mean age of subjects was 43.1 year, and the range
was 27–67 year. A total of 17 normal subjects from the
Cambridge area served as a control group. The mean
age of the normal subjects was 41.1 year, with a range
of 28–61 year. All the normal subjects passed the FM
D-15 and had normal Rayleigh matches. These subjects
had a minimum visual acuity of 1 (6:6), had normal
fundi, and had no history of ocular or systemic condi-
tions known to affect colour discrimination, and were
not taking any medications known to affect colour
vision.
2.2. Method of examination
Each DOA patient performed a battery of colour
vision tests monocularly, including the enlarged FM
D-15 (the ‘PV-16’, Precision Vision, Villa Park, Illi-
nois), an enlarged version of the ‘minimalist test’ de-
scribed by Mollon et al. 1991 [28], the Nagel
anomaloscope and the newly designed computerised
colour vision test described below. Visual acuity (using
an EDTRS letter chart), refraction and direct ophthal-
moscopy were also performed at the same visit. Visual
field assessment was also conducted on a number of
subjects using a standard 30-2 program on the
Humphrey visual field analyser.
2.3. Design of the computerised colour 6ision test
In its underlying principles, the present test resembles
the test described by Mollon and Reffin [29] and Regan
et al. [30]. The stimuli were generated by a State
machine G8 graphics card and an Acorn A5000 com-
puter and were presented on a graphics monitor (Sony
GDM-1936). The system was calibrated using a
Pritchard PR650 telespectroradiometer, and a Minolta
CS-100 chroma-meter. The basic system had a resolu-
tion of 8 bits per gun, but the chromatic resolution was
increased by ‘dithering’ [31]: alternating pixels were set
to different chromaticities chosen by the computer to
produce the closest chromaticity to that desired.
To determine the patient’s chromatic discrimination,
four discs are presented on a 2 cd:m2 neutral back-
ground in a diamond-shaped array; each subtends 4° at
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Table 2
Results for DOA subjects
AgeF:ID AO Sex VA VF PV-16 Nagel M-R test Ellipse (A,B) u
B-DB 31 7 M R 0.1 ST Two inversions (18–58) 0.039 T(3),D(3),P(1) (12.9, 59.3) 100.9
L 0.125 ST Two inversions (11–63) 0.128 T(2),D(1),P(2) (15.6, 36.1) 105.2
39 M R 0.125C-JC —67 Tritan ( 0–73) 0.438 T(5),D(5),P(—) (93.5, 113) 108.0
L 0.2 — Anarchic ( 0–73) 0.386 T(—),D(6),P(—) (93.5, 109.3) 144.9
66D-DB 30 F R 0.125 — Anarchic ( 0–73) 0.006 T(—),D(—),P(—) (60.8, 137.1) 92.5
L 0.125 — Anarchic ( 0–73) 0.124 T(—),D(—),P(—) NA
10 F R 0.32 GST36 AnarchicD-JB ( 0–60) 0.084 T(—),D(4),P(—) (53.2, 108.8) 103.9
L 0.32 G Anarchic ( 0–62) 0.094 T(—),D(6),P(—) (54.5, 115.9) 105.3
8 F R 0.2 SIN61 AnarchicK-JK ( 0–73) 0.069 T(—),D(5),P(4) (47.7, 81.6) 124.4
L 0.16 — Anarchic ( 0–73) 0.101 T(—),D(7),P(—) (47.7, 135.6) 105.5
58K-SM 7 F R 0.32 GCI Anarchic ( 0–73) 0.031 T(—),D(—),P(—) (48.5, 144.1) 95.3
L 0.2 — Anarchic ( 0–73) 0.010 T(—),D(—),P(—) (63.1, 137) 94.2
4 F R 0.06 CCK-JJ Anarchic38 Not performed T(—),D(—),P(—) (67.5, 110.6) 115.8
L 0.06 — Anarchic Not performed T(—),D(—),P(—) (56.4, 130.4) 98.8
55M-DTa 5 M R 0.04 — Tritan Not performed T(3),D(6),T(3) (58.2, 96.9) 113.7
L 0.04 — Protan Not performed T(4),D(5),P(—) (73.0, 117.2) 113.9
11 F R 0.05 —29 AnarchicM-JT Not performed T(—),D(—),P(—) (84.7, 110.3) 136.9
L 0.05 — Anarchic Not performed T(—),D(—),P(—) (90.1, 126.1) 111
3 F R 0.08 G34 PassM-JW Not performed T(2),D(3),P(2) (36.7, 74.4) 121.5
L 0.06 — Pass Not performed T(2),D(2),P(2) (39.0, 79.6) 121.3
5 F R 0.16 GCIM-SM Anarchic33 ( 0–73) 0.052 T(5),D(6),P(—) (61.2, 120.2) 116.3
L 0.1 — Anarchic ( 0–73) 0.061 T(3),D(—),P(—) (47.2, 79.4) 133.1
27M-DTb 1 F R 0.05 GS Protan Not performed T(3),D(—),P(—) (45.4, 83.6) 173.5
L 0.05 — Protan Not performed T(4),D(—),P(—) (31.7, 99.9) 169.5
25 F R 0.8 N43 PassO-JW (36–42) 0.024 T(2),D(1),P(0.5) ( 7.7, 9.9) 111.8
L 0.8 — One crossinga (38–42) 0.053 T(5),D(2),P(2) ( 8.2, 16.4) 89.1
29Q-JS 4 F R 0.2 GCC Anarchic ( 0–73) 0.136 T(4),D(7),P(5) (38.0, 87.2) 138.5
L 0.8 — Four inversions (37–42) 0.024 T(2),D(1),P(2) (11.9, 14.4) 86.3
Y-JM 36 5 M R 0.25 — Scotopic ( 0–73) 0.357 T(—),D(—),P(—) (51.1, 81.6) 10.4
L 0.2 — Scotopic ( 0–73) 0.392 T(—),D(—),P(—) (69.7, 82.2) 177.9
39Z-FB 2 M R 0.04 — Protan Unreliable T(4),D(—),P(—) (20.7, 65.2) 176.4
L 0.125 — Protan ( 0–73) 0.178 T(2),D(—),P(—) (22.9, 78.3) 168
9 M R 0.05 —41 AnarchicZ-M B ( 0–73) 0.079 T(—),D(—),P(—) (54.1, 117.3) 117.9
L 0.05 — Refused Not performed T(—),D(—),P(—) (70.5, 90.5) 174.3
F:ID, family:subject code; AO, age of onset of symptoms of DOA; VA, visual acuity (Snellen fraction); VF, visual fields; S, superior field defect;
IN, inferior-nasal field defect; CI, with central island of sparing; CC, centro-caecal scotoma; G, generalised loss; ST, superior temporal field defect;
N, normal; PV-16, enlarged FM D-15.
a Subject made one crossing from chip 5 to 15.
Nagel anomaloscope: the values for matching range are enclosed in brackets. Also given (outside brackets) is the gradient of the brightness settings
of the 589-nm primary. A deuteranope should have a gradient of around 0, and a protanope a gradient of around 0.384. The (unrelated)
patients C-JC and Y-JM displayed protanopic brightness matches, recalling the patients described by Aulhorn and Gruetzner: such patients could
simply be suffering from a concomitant X-linked colour deficiency or could represent a distinct phenotypic form of DOA.
M-R, Mollon-Reffin test: numbers in brackets represent the least saturated chips that the subject could discriminate for the protan (P), deutan
(D), and tritan (T) axes. A dash indicates that the subject failed to discriminate the most saturated chip.
Ellipse: as for Table 1.
1 m, and is separated by 2.5° from adjacent discs. On
each presentation, one of the discs differs in chromatic-
ity from the remaining three (which remain neutral in
hue; u %0.211, 6%0.474 or x0.333, y0.333): the
subject’s task is to determine which disc differs from the
others in colour. An oddity task of this kind has the
advantage that it is cognitively one of the easiest tasks
for a patient to perform. The luminance of each disc is
set randomly to a value lying between 6 and 26 cd:m2,
and the chromaticity of the test disc is varied so that
colour discrimination is probed along 20 axes spaced
18° apart in CIE 1976 L*u*v* space. The program uses
a staircase procedure to determine the minimum satura-
tion at which the coloured disc can be discriminated
from the neutral discs. The threshold data, when plot-
ted as points in the CIE 1976 u % 6 % chromaticity dia-
gram, may be fitted with a least-squares ellipse centred
at the chromaticity coordinates of the neutral discs, as
described by Regan et al. [30]. In addition, we esti-
mated the achromatic area of the chromaticity diagram
by calculating the area of the polygon obtained by
joining the points representing the chromaticity coordi-
nates of the threshold values in the CIE 1976 u % 6 %
chromaticity diagram. As Regan, Reffin & Mollon
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Fig. 1. Tritan versus red-green discrimination in thousandths of CIE 1976 u % 6 % units. Open circles represent data for the right eye, and closed
triangles for the left eye. Tritan discrimination is obtained by averaging the values of threshold for the 270° and 288° axes (0°:180° correspond
to the u % axis, and 90°:270° correspond to the 6% axis). The values for red-green discrimination were obtained by averaging thresholds for the 342°,
0° and 18° axes. The chromaticity of the screen phosphors enabled greater tritan excursions; for the purposes of this graph the maximum tritan
threshold has been limited to 150 (0.15 CIE 1976 u % 6 % units). The control group had a mean tritan score of 4.71 with a standard deviation of 1.87.
The mean value for the red-green score was 3.29, with a standard deviation of 1.28.
note, the origins of this form of colour vision assess-
ment can be traced to the 19th century: Kolbe pub-
lished discrimination ellipses for daltonians in 1881
([32]).
3. Results and discussion
The results for the control and DOA groups are
summarised in Tables 1 and 2. For the DOA group,
visual acuity ranged from 0.8 (6:7.5) to 0.04 (6:150).
Even those subjects with severely reduced visual acuity
found the test simple to perform.
The mean achromatic area for the DOA group, in
square thousandth CIE 1976 u % 6 % units, was 20920 and
the standard deviation 14612. By comparison, the mean
achromatic area for the control group was 110.0 and
the standard deviation 63.49.
Fig. 1 shows the mean of the patients’ thresholds for
the two axes closest to a tritan line, and the mean of the
thresholds for three axes close to the protan and deutan
lines. As a general rule, tritan discrimination was
poorer than red-green discrimination when expressed as
CIE 1976 u % 6 % units. However, no patient displayed a
truly isolated loss in tritan discrimination when assessed
with the complete battery of tests: although B-DB and
O-JW (left eye only) had elongated tritan ellipses, they
also made red-green errors on the Mollon-Reffin test,
and B-DB had a widened Rayleigh match. As might be
expected from previous reports of the condition, we
observed patients whose ellipses were well aligned to
different classical confusion axes, as can be seen from
Table 2.
For the averaged data from the right and left eyes,
there was no significant correlation between achromatic
area and age (Spearman r0.266). Similarly, the
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Fig. 2. Thresholds plotted in the CIE 1976 u % 6 % chromaticity diagram for: (a) a normal subject; (b) a protanope (CGR, aged 42year); (c) a
deuteranope (GRM, aged 62 year); (d) a progressive cone dystrophy patient with an acquired tritan defect (LF, aged 22year); (e) and (f) two
female cousins, M-JW and M-DTb, with DOA; and (g) and (h) the right and left eyes of patient Q-JS. The incomplete triangle represents the limit
of the gamut that could be produced by the monitor. Open circles indicate that the threshold exceeded that which could be produced by the
monitor. The line closest to the horizontal represents the protan line, the line closest to the vertical represents the tritan line and the line rotated
slightly clockwise from the protan line represents the deutan line. Ellipse dimensions are (12.3, 118.3) 6.2 for subject CGR, (17.1, 142.0) 171.3 for
subject GRM, and (12.8, 53.5) 90.2 for subject LF. Details of ellipse dimensions for the remaining subjects can be found in Tables 1 and 2.
Spearman r values for visual acuity and age and for
achromatic area and visual acuity were not significant
(0.219 and 0.323, respectively). Our sample consists
mainly of those with poor acuity and this may have
reduced the correlation coefficient for achromatic area
versus acuity. It is warranted to note that the three eyes
(from two patients) with the best acuity (0.8 or Snellen
6:7.5) also had the best colour discrimination, in that
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Fig. 2. (Continued)
they had the smallest achromatic areas and were also
the only eyes with normal Rayleigh matches. However,
these eyes did not display perfectly normal colour vi-
sion. They exhibited both tritan and red-green errors
when tested with the Mollon minimal test and with the
SPP plates. On the computerised test, O-JW’s red-green
scores were 4.9 and 2.9, and her tritan scores were 6.5
and 15 for the right and the left eyes, respectively. The
red-green and tritan scores for Q-JS’s left eye were 9.3
and 10.4 (the mean red-green score for normals was
3.29, and the standard deviation 1.28; the mean for the
tritan score was 4.71, and the standard deviation 1.87).
Of particular interest are two cousins (M-JW and
M-DTb) of the same family who displayed a marked
difference in residual colour discrimination. As can be
seen in Table 2, these patients had a similar level of
visual acuity. It is interesting that M-DTb’s sister (M-
SM) displayed a similarly oriented ellipse to that of her
cousin M-JW. The differences observed between M-
DTb and other members of her family are unusual:
most subjects within families M and K showed an
agreement in results. Congenital colour deficiency is
unlikely to be the cause of the differences observed
between M-DTb and her cousin M-JW, as both sub-
jects are female. The ellipses obtained for these subjects
are plotted in Fig. 2e, f. One DOA subject displayed an
asymmetry in colour vision between the right and left
eyes (Fig. 2g, h). This patient also displayed an asym-
metry in acuity: acuity for the right eye was 0.2 (6:30),
and for the left, 0.8 (6:7.5).
It is unlikely that variations amongst our patients
arose from differences in fixation due to the presence of
centro-caecal scotomata. Chromatic discrimination is
reduced only very slightly at 10° eccentricity in one
normal observer tested (MPS, male aged 24 year):
taking the mean of the four quadrants tested (nasal,
temporal, superior and inferior) the achromatic area
increases by 0.13 log unit. When fixation is 20° from the
centre of the screen, then the achromatic area increases
by 0.7 log unit. Beyond 20°, there is a marked increase
in chromatic threshold. In view of the fact that those
patients using eccentric viewing:eccentric fixation did
not appear to be using extra-macular fixation when
assessed ophthalmoscopically, one may safely assume
that they used an area within about 10° of the fovea to
fixate the test targets.
Does a genetic heterogeneity underlie the phenotypic
variations in the colour vision seen in DOA? Our
finding of differences within family M suggests that
some of the variation is not genetic in origin; and
molecular genetic studies have consistently linked DOA
to chromosome 3q28. However, the condition might yet
prove to be heterogeneous at the molecular level: in
much the same way as the various mutations of the
rhodopsin gene give rise to clinically distinct forms of
autosomal dominant retinitis pigmentosa [33], there
may be a variety of mutations of a single gene all giving
rise to DOA. If such genotypic variations were iden-
tified, it might prove possible to correlate them with the
variations in colour deficiency in DOA.
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